Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women
Authors:
- P. DupontPDP. Dupont
- L. CusanLCL. Cusan
- M. TremblayMTM. Tremblay
- J. RiouxJRJ. Rioux
- D. CloutierDCD. Cloutier
- J. MaillouxJMJ. Mailloux
- B. De LignièresBLB. De Lignières
- J. GutkowskaJGJ. Gutkowska
- H. BoucherHBH. Boucher
- A. BélangerABA. Bélanger
- D.L. MoyerDMD.L. Moyer
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Postmenopausal Estrogen Use and Coronary AtherosclerosisAnnals of Internal Medicine, 1988
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Does Calcium Supplementation Prevent Postmenopausal Bone Loss?New England Journal of Medicine, 1987
- A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving EstrogensNew England Journal of Medicine, 1986
- Estrogen use and cardiovascular diseaseAmerican Journal of Obstetrics and Gynecology, 1986
- Oral contraceptives and hepatocellular carcinoma.BMJ, 1986
- Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous AdministrationThe Journal of Clinical Endocrinology & Metabolism, 1986
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50New England Journal of Medicine, 1985
- Effect of Estrogen Treatment on Coagulation and Fibrinolysis in Postmenopausal WomenGynecologic and Obstetric Investigation, 1978